Pharmacy compounding: implications of the 2012 meningitis outbreak : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Twelfth Congress, second session on examining pharmacy compounding, focusing on implications of the 2012 meningitis outbreak, November 15, 2012.
Saved in:
Corporate Author: | United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions (Author) |
---|---|
Format: | Government Document Electronic eBook |
Language: | English |
Published: |
Washington :
U.S. Government Publishing Office,
2015.
|
Series: | U.S. Congressional documents. Congressional hearings.
COVID-19: pandemics past and present. |
Subjects: | |
Online Access: | CONNECT CONNECT |
Similar Items
-
The fungal meningitis outbreak : could it have been prevented? : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Twelfth Congress, second session, November 14, 2012.
Published: (2014) -
Drug compounding : FDA authority and possible issues for Congress /
by: Bodie, Agata
Published: (2018) -
Pharmaceutical compounding: proposed legislative solution : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Thirteenth Congress, first session on examining pharmaceutical compounding, focusing on a proposed legislative solution. May 9, 2013.
Published: (2016) -
Reforming the drug compounding regulatory framework : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, first session, July 16, 2013.
Published: (2014) -
Reforming the drug compounding regulatory framework : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, first session, July 16, 2013.
Published: (2014)